New Monoclonal Antibodies Specific for Different Epitopes of the Spike Protein of SARS-CoV-2 and Its Major Variants: Additional Tools for a More Specific COVID-19 Diagnosis

The emergence of the new pathogen SARS-CoV-2 determined a rapid need for monoclonal antibodies (mAbs) to detect the virus in biological fluids as a rapid tool to identify infected individuals to be treated or quarantined. The majority of commercially available antigenic tests for SARS-CoV-2 rely on...

Descripción completa

Detalles Bibliográficos
Autores principales: Mariotti, Sabrina, Chiantore, Maria Vincenza, Teloni, Raffaela, Iacobino, Angelo, Capocefalo, Antonio, Michelini, Zuleika, Borghi, Martina, Baggieri, Melissa, Marchi, Antonella, Bucci, Paola, Gioacchini, Silvia, D’Amelio, Raffaele, Brouwer, Philip J. M., Sandini, Silvia, Acchioni, Chiara, Sgarbanti, Marco, Di Virgilio, Antonio, Grasso, Felicia, Cara, Andrea, Negri, Donatella, Magurano, Fabio, Di Bonito, Paola, Nisini, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953266/
https://www.ncbi.nlm.nih.gov/pubmed/36831149
http://dx.doi.org/10.3390/biomedicines11020610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953266/
https://www.ncbi.nlm.nih.gov/pubmed/36831149
http://dx.doi.org/10.3390/biomedicines11020610

Ejemplares similares